P

PAS Research | Tampa, FL

Research site

(Unclaimed)

Location

4444 East Fletcher Avenue, Suite C, Tampa, Florida, United States of America

Site insights

Top conditions

Top treatments

Erenumab

Obeldesivir

Parent organization

This site is a part of PAS Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 16 total trials

A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children

The purpose of this clinical trial is to learn about the safety, extent of the side effects, and immune responses of the study vaccine (called varian...

Enrolling

COVID-19

SARS-CoV-2 Virus

Biological: Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 10 microgram dose

Biological: Variant-adapted BNT162b2 (Omicron XBB.1.5) 3 microgram dose

Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers (CORAL)

This study is a Phase III, randomized, single-blind, placebo-controlled, multi-center study to be conducted in healthy infants and toddlers aged 6 mo...

Enrolling

RSV Immunization

Biological: Diphtheria, tetanus, pertussis, Haemophilus influenzae type b and poliomyelitis vaccine

Biological: Streptococcus pneumoniae vaccine

Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents

The purpose of VAN00010 study is to assess the safety and immunogenicity of the investigational pentavalent meningococcal ABCYW vaccine in adults and...

Active, not recruiting

Meningococcal Infection

Healthy Volunteers

Biological: Pentavalent Meningococcal ABCYW vaccine

Biological: MenABCYW conjugate vaccine

Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273.214 SARS-CoV-2 (COVID-19) Vaccine in Infants (BabyCOVE)

The study will evaluate the safety, tolerability, reactogenicity, and effectiveness of mRNA-1273.214 severe acute respiratory syndrome coronavirus 2...

Active, not recruiting

SARS-CoV-2

Biological: mRNA-1273.214

Other: Placebo